While I believe Pfizer will rebound eventually, it will take some time to do so, and it may not occur in 2026. In the meantime, other healthcare leaders could perform significantly better this year ...
Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...
A controversial housing scheme that would change the face of Hyde ’s green space forever is due to be scrutinised again. The ...
It's understood the writing was on the wall for the EU-Mercosur agreement not long after the meeting of EU ambassadors got ...
A few days earlier, on December 11, Edison International (NYSE:EIX) declared a quarterly common stock dividend of $0.8775 per ...
Five sensational income stocks -- sporting yields ranging from 5.3% to 13.1% -- can fatten investors' pocketbooks in the new ...
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback